Regulation issues Using synthetic GH can be banned in competitive sports
Heres whats known and whats still being investigated when it comes to RA and GLP-1 safety and efficacy, as well as expert advice on what you should consider before you start taking the weight loss drugs
If you notice an injection site reaction that is getting larger, feels hot to the touch, or is accompanied by a fever, you should contact a healthcare professional immediately
But several profiles make thorough baseline testing genuinely non-negotiable: Any history of type 2 diabetes or prediabetes (HbA1c monitoring changes medication management) Personal or family history of medullary thyroid carcinoma or MEN2 syndrome (direct contraindication) History of pancreatitis (GLP-1 medications carry a pancreatitis warning) Chronic kidney disease or known renal impairment Current use of insulin, metformin, or other glucose-lowering medications (drug interaction and hypoglycemia risk) History of eating disorders, severe gastroparesis, or significant GI conditions PCOS or other hormonal conditions that drive weight-related metabolic dysfunction 1.3 What clinical guidelines say The American Diabetes Association (ADA) Standards of Medical Care recommend HbA1c, renal function, and lipid panels as part of baseline metabolic assessment before initiating GLP-1 therapy in patients with diabetes
It carries the same cardiovascular risk-reduction indication as the injectable form
(2014) Once-weekly albiglutide versus once-daily liraglutide in patients with type 2 diabetes inadequately controlled on oral drugs (HARMONY 7): a randomised, open-label, multicentre, non-inferiority phase 3 study
